Mississippi HB 675: Newborn screening program; include spinal muscular atrophy (SMA) in those conditions covered in.

Bill Text

HB 675 (As Introduced) - 2020 Regular Session 

MISSISSIPPI LEGISLATURE

2020 Regular Session

To: Public Health and Human Services

By: Representative Bennett

House Bill 675

AN ACT TO AMEND SECTION 41-21-201, MISSISSIPPI CODE OF 1972, 
TO INCLUDE SPINAL MUSCULAR ATROPHY (SMA) IN THOSE CONDITIONS COVERED IN THE 
COMPREHENSIVE NEWBORN SCREENING PROGRAM ADMINISTERED BY THE STATE DEPARTMENT OF 
HEALTH; AND FOR RELATED PURPOSES.

���� BE IT ENACTED BY THE 
LEGISLATURE OF THE STATE OF MISSISSIPPI:

���� SECTION 1.� Section 
41-21-201, Mississippi Code of 1972, is amended as follows:

���� 41-21-201.� (1)� The State 
Department of Health shall establish, maintain and carry out a comprehensive 
newborn screening program designed to detect hypothyroidism, phenylketonuria 
(PKU), hemoglobinopathy, congenital adrenal hyperplasia (CAH), galactosemia, spinal 
muscular atrophy (SMA) and such other conditions as specified by the State 
Board of Health and as recommended by the American Academy of Pediatrics.� The 
State Board of Health shall adopt any rules and regulations necessary to 
accomplish the program.

���� (2)� The State Board of 
Health shall determine and specify the conditions that will be included in the 
comprehensive newborn screening program in addition to those conditions named 
in subsection (1) of this section, upon the advice and recommendations of a 
genetics advisory committee and in accordance with the recommendations of the 
American Academy of Pediatrics.� The advisory committee shall be appointed by 
the Executive Director of the State Department of Health, and shall include at 
least two (2) pediatricians and one (1) consumer representative from a family 
that has experience with a newborn infant with an abnormal screening test.� The 
State Department of Health shall maintain a list of each of the conditions 
included in the comprehensive newborn screening program, which shall be made 
available to physicians and other health care providers who are required to 
provide for newborn screening testing under Section 41-21-203.

���� (3) �The State 
Department of Health shall develop information materials about newborn 
screening tests that are available, which may be used by physicians and other 
health care providers to inform pregnant women and parents.

���� SECTION 2.� This act 
shall take effect and be in force from and after July 1, 2020.